GSA Capital Partners’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $437K | Buy |
+117,719
| New | +$437K | 0.03% | 1014 |
|
|
2025
Q1 | – | Sell |
-16,743
| Closed | -$93K | – | 1783 |
|
|
2024
Q4 | $93K | Sell |
16,743
-20,919
| -56% | -$116K | 0.01% | 1515 |
|
|
2024
Q3 | $407K | Sell |
37,662
-27,220
| -42% | -$294K | 0.03% | 1047 |
|
|
2024
Q2 | $1.36M | Buy |
+64,882
| New | +$1.36M | 0.1% | 315 |
|
|
2022
Q4 | – | Sell |
-23,997
| Closed | -$193K | – | 1594 |
|
|
2022
Q3 | $193K | Buy |
+23,997
| New | +$193K | 0.03% | 1236 |
|